Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)Research in context
Summary: Background: The only disease-modifying treatment currently available for allergic rhinitis (AR) is allergen immunotherapy (AIT). The main objective of the EfficAPSI real-world study (RWS) was to evaluate the impact of liquid sublingual immunotherapy (SLIT-liquid) on asthma onset and evoluti...
Saved in:
Main Authors: | Pascal Demoly (Author), Mathieu Molimard (Author), Jean-François Bergmann (Author), Bertrand Delaisi (Author), Amandine Gouverneur (Author), Jade Vadel (Author), Cédric Collin (Author), Laurence Girard (Author), Silvia Scurati (Author), Philippe Devillier (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction to "Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)" [The Lancet Regional Health - Europe 41 (2024) 100915]
by: Pascal Demoly, et al.
Published: (2024) -
EFFICENCY OF PHOTOACTIVATED DISINFECTION ON EXPERIMENTAL BIOFILM - SCANING ELECTRON MICROSCOPY RESULTS
by: Ivan Filipov, et al.
Published: (2013) -
Treating allergic rhinitis by sublingual immunotherapy: a review
by: Cristoforo Incorvaia, et al.
Published: (2012) -
The Effectiveness of Sublingual Allergen-Specific Immunotherapy in Children with Allergic Rhinitis
by: M.P. Prokhorova
Published: (2015) -
Sublingual Immunotherapy Decreased the Serum Levels of Interleukin-36γ in Allergic Rhinitis
by: Xiaowei Qin, et al.
Published: (2024)